Fairness, poverty, and cost-effectiveness impact of two doses of corticosteroid injection given to pregnant women at risk of delivering before term
Not Applicable
- Conditions
- Health Condition 1: P220- Respiratory distress syndrome of newborn
- Registration Number
- CTRI/2023/07/055525
- Lead Sponsor
- Translational Health Science and Technology Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The study population includes pregnant women coming to the hospital for delivery in the late preterm period (enrolled in the main ACTION III trial) and their newborn.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of families with Catastrophic <br/ ><br>Healthcare Expenditure (CHE) due to in-patient <br/ ><br>and out-patient health care seeking for the <br/ ><br>ACTION III babyTimepoint: Proportion of families with Catastrophic <br/ ><br>Healthcare Expenditure (CHE) due to in-patient <br/ ><br>and out-patient health care seeking for the <br/ ><br>ACTION III baby
- Secondary Outcome Measures
Name Time Method Cost per additional disability-adjusted life yearTimepoint: Enrolment to 28-days post-partum;Equity impactTimepoint: Enrolment to 28-days post-partum;Extended cost effectivenessTimepoint: Enrolment to 28-days post-partum;ImpoverishmentTimepoint: Enrolment to 28-days post-partum;Incremental Cost-Effectiveness RatioTimepoint: Enrolment to 28-days post-partum;Mean out-of-pocket expenditureTimepoint: Enrolment to 28-days post-partum